Millipore Sigma Vibrant Logo

528283 Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem

The Polo-like Kinase Inhibitor II, BTO-1, also referenced under CAS 40647-02-7, controls the biological activity of Polo-like Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: 5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide

View This Product on Sigma-Aldrich
528283
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
40647-02-7C₉H₄N₄O₄S

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
528283-2MGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 2 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays (IC50 = 8.0 µM) and suppress the phosphorylation of cellular Plk1 substrate Cdc25C in rat kangaroo kidney-derived PTK cells (75% inhibition at 6.3 µM). BTO-1 treatment of cultured cells results in mitosis defects consistent with loss-of-Plk1 phenotypes seen in Plk1 RNAi-treated U20S cells, including the appearance of monopolar spindles and the reduction of γ-tubulin at the centrosomes. Plk1 inhibition by BTO-1 in HeLa cells results in a blockage of Rho and Rho-GEF recruitment, which is essential for the assembly of a functional contractile ring.
      Catalogue Number528283
      Brand Family Calbiochem®
      Synonyms5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide
      References
      ReferencesBrennan, I.M., et al. 2007. PloS ONE 2, e409.
      Peters, U., et al. 2006. Nat. Chem. Biol. 2, 618.
      McInnes, C., et al. 2006. Nat. Chem. Biol. 2, 608.
      Product Information
      CAS number40647-02-7
      FormBeige to brown solid
      Hill FormulaC₉H₄N₄O₄S
      Chemical formulaC₉H₄N₄O₄S
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22-36/37/38

      Harmful by inhalation, in contact with skin and if swallowed.
      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-36/37

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing and gloves.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      528283-2MGCN 04055977196580

      Documentation

      Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      528283

      参考資料

      参考資料の概要
      Brennan, I.M., et al. 2007. PloS ONE 2, e409.
      Peters, U., et al. 2006. Nat. Chem. Biol. 2, 618.
      McInnes, C., et al. 2006. Nat. Chem. Biol. 2, 608.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-August-2016 JSW
      Synonyms5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide
      DescriptionA cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays (IC50 = 8.0 µM) and suppress the phosphorylation of cellular Plk1 substrate Cdc25C in rat kangaroo kidney-derived PTK cells (75% inhibition at 6.3 µM). BTO-1 treatment of cultured cells results in mitosis defects consistent with loss-of-Plk1 phenotypes seen in Plk1 RNAi-treated U20S cells, including the appearance of monopolar spindles and the reduction of γ-tubulin at the centrosomes. Plk1 inhibition by BTO-1 in HeLa cells results in a blockage of Rho and Rho-GEF recruitment, which is essential for the assembly of a functional contractile ring.
      FormBeige to brown solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number40647-02-7
      Chemical formulaC₉H₄N₄O₄S
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (1 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Harmful
      ReferencesBrennan, I.M., et al. 2007. PloS ONE 2, e409.
      Peters, U., et al. 2006. Nat. Chem. Biol. 2, 618.
      McInnes, C., et al. 2006. Nat. Chem. Biol. 2, 608.